S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
Log in

NASDAQ:IIVI - II-VI Stock Price, Forecast & News

$34.72
-2.39 (-6.44 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
$34.34
Now: $34.72
$36.77
50-Day Range
$33.65
MA: $36.19
$37.91
52-Week Range
$26.93
Now: $34.72
$43.49
Volume1.50 million shs
Average Volume1.54 million shs
Market Capitalization$3.16 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.17
II-VI Incorporated develops, manufactures, and markets engineered materials, and optoelectronic components and devices worldwide. The company operates in three segments: II-VI Laser Solutions, II-VI Photonics, and II-VI Performance Products. The II-VI Laser Solutions segment offers optical and electro-optical components and materials primarily used in high-power CO2 lasers; fiber-delivered beam delivery systems, and processing tools and direct diode lasers for industrial lasers; direct diode laser modules, sub-systems, and systems; super-hard materials processing laser systems; and compound semiconductor epitaxial and gallium arsenide wafers. Read More…

Industry, Sector and Symbol

Industry Optical instruments & lenses
Sub-IndustryElectrical Components & Equipment
SectorIndustrial Products
Current SymbolNASDAQ:IIVI
CUSIP90210410
Phone724-352-4455

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.36 billion
Cash Flow$3.18 per share
Book Value$22.68 per share

Profitability

Net Income$107.52 million

Miscellaneous

Employees12,487
Market Cap$3.16 billion
Next Earnings Date5/6/2020 (Estimated)
OptionableOptionable

Receive IIVI News and Ratings via Email

Sign-up to receive the latest news and ratings for IIVI and its competitors with MarketBeat's FREE daily newsletter.


II-VI (NASDAQ:IIVI) Frequently Asked Questions

What is II-VI's stock symbol?

II-VI trades on the NASDAQ under the ticker symbol "IIVI."

How were II-VI's earnings last quarter?

II-VI, Inc. (NASDAQ:IIVI) posted its quarterly earnings data on Monday, February, 10th. The scientific and technical instruments company reported $0.36 EPS for the quarter, meeting the Thomson Reuters' consensus estimate of $0.36. The scientific and technical instruments company earned $666.30 million during the quarter, compared to analyst estimates of $610.30 million. II-VI had a negative net margin of 4.18% and a negative return on equity of 4.44%. The business's revenue for the quarter was up 94.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.71 earnings per share. View II-VI's Earnings History.

When is II-VI's next earnings date?

II-VI is scheduled to release their next quarterly earnings announcement on Wednesday, May 6th 2020. View Earnings Estimates for II-VI.

What guidance has II-VI issued on next quarter's earnings?

II-VI updated its third quarter earnings guidance on Monday, February, 10th. The company provided earnings per share (EPS) guidance of $0.02-0.32 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.39. The company issued revenue guidance of $550-600 million, compared to the consensus revenue estimate of $616.17 million.

What price target have analysts set for IIVI?

15 brokers have issued 1-year price targets for II-VI's stock. Their forecasts range from $30.00 to $53.00. On average, they anticipate II-VI's stock price to reach $41.31 in the next twelve months. This suggests a possible upside of 19.0% from the stock's current price. View Analyst Price Targets for II-VI.

What is the consensus analysts' recommendation for II-VI?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for II-VI in the last year. There are currently 5 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for II-VI.

What are Wall Street analysts saying about II-VI stock?

Here are some recent quotes from research analysts about II-VI stock:
  • 1. According to Zacks Investment Research, "II-VI Incorporated designs, manufactures and markets optical and opto-electronic components, devices and materials for infrared, near-infrared, visible light, x-ray and gamma ray instrumentation. The Company's infrared optics business manufactures optical and opto-electronic components sold under the II-VI brand name and used primarily in CO2 lasers. The Company's near-infrared optics business manufactures near-infrared & visible light products for industrial, scientific, military & medical instruments and laser gain materials and products for solid-state YAG and YLF lasers at the Company's VLOC subsidiary. The Company's military infrared optics business manufactures infrared products for military applications under the Exotic Electro-Optics brand name. " (2/12/2020)
  • 2. Northland Securities analysts commented, "We are lowering our FY20 ests and lower our PT slightly on a mixed FQ4 report and outlook Tues AM from IIVI, though we maintain our OP rating focused on the synergy potential of the FNSR deal, which the company now hopes to close in the Fall". Stand alone, optical strength, bolstered by a $15M pull in from FQ1, continues albeit with slower order growth, while book to bills in Laser Solutions, despite expectations for a strong 3DS ramp in Products were very weak." (8/14/2019)

Has II-VI been receiving favorable news coverage?

Media headlines about IIVI stock have been trending somewhat positive this week, InfoTrie Sentiment reports. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. II-VI earned a media sentiment score of 0.6 on InfoTrie's scale. They also assigned news coverage about the scientific and technical instruments company a news buzz of 7.0 out of 10, indicating that recent news coverage is likely to have an impact on the stock's share price in the next several days. View News Stories for II-VI.

Who are some of II-VI's key competitors?

What other stocks do shareholders of II-VI own?

Based on aggregate information from My MarketBeat watchlists, some companies that other II-VI investors own include NVIDIA (NVDA), Alibaba Group (BABA), Lumentum (LITE), Walt Disney (DIS), Verizon Communications (VZ), Netflix (NFLX), Tesla (TSLA), CVS Health (CVS), Advanced Micro Devices (AMD) and Editas Medicine (EDIT).

Who are II-VI's key executives?

II-VI's management team includes the folowing people:
  • Dr. Vincent D. Mattera Jr., Pres, CEO & Director (Age 63)
  • Ms. Mary Jane Raymond, CFO, Treasurer & Assistant Sec. (Age 59)
  • Mr. Gary Alan Kapusta, Chief Operating Officer (Age 59)
  • Dr. Giovanni Barbarossa, CTO & Pres of Laser Solutions Segment (Age 59)
  • Ms. Jo Anne Schwendinger, Chief Legal & Compliance Officer and Sec. (Age 64)

Who are II-VI's major shareholders?

II-VI's stock is owned by many different of retail and institutional investors. Top institutional shareholders include State Street Corp (3.00%), Barrow Hanley Mewhinney & Strauss LLC (2.63%), Robecosam AG (1.89%), Robecosam AG (1.89%), Iridian Asset Management LLC CT (1.53%) and Franklin Resources Inc. (1.46%). Company insiders that own II-VI stock include Christopher Koeppen, David G Wagner, Francis J Kramer, Howard H Xia, Joseph J Corasanti, Marc Y E Pelaez, Mary Jane Raymond, Shaker Sadasivam and Vincent D Mattera Jr. View Institutional Ownership Trends for II-VI.

Which institutional investors are selling II-VI stock?

IIVI stock was sold by a variety of institutional investors in the last quarter, including Mason Street Advisors LLC, DNB Asset Management AS, State of New Jersey Common Pension Fund D, Principal Financial Group Inc., Victory Capital Management Inc., Victory Capital Management Inc., State Street Corp and Falcon Point Capital LLC. Company insiders that have sold II-VI company stock in the last year include Christopher Koeppen, David G Wagner, Francis J Kramer, Howard H Xia, Marc Y E Pelaez, Mary Jane Raymond and Vincent D Mattera Jr. View Insider Buying and Selling for II-VI.

Which institutional investors are buying II-VI stock?

IIVI stock was bought by a variety of institutional investors in the last quarter, including Iridian Asset Management LLC CT, Franklin Resources Inc., Mariner LLC, Barrow Hanley Mewhinney & Strauss LLC, Robecosam AG, Robecosam AG, Pinnacle Associates Ltd. and Snow Capital Management LP. Company insiders that have bought II-VI stock in the last two years include Joseph J Corasanti and Shaker Sadasivam. View Insider Buying and Selling for II-VI.

How do I buy shares of II-VI?

Shares of IIVI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is II-VI's stock price today?

One share of IIVI stock can currently be purchased for approximately $34.72.

How big of a company is II-VI?

II-VI has a market capitalization of $3.16 billion and generates $1.36 billion in revenue each year. The scientific and technical instruments company earns $107.52 million in net income (profit) each year or $1.63 on an earnings per share basis. II-VI employs 12,487 workers across the globe.View Additional Information About II-VI.

What is II-VI's official website?

The official website for II-VI is http://www.ii-vi.com/.

How can I contact II-VI?

II-VI's mailing address is 375 SAXONBURG BOULEVARD, SAXONBURG PA, 16056. The scientific and technical instruments company can be reached via phone at 724-352-4455 or via email at [email protected]


MarketBeat Community Rating for II-VI (NASDAQ IIVI)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  407 (Vote Outperform)
Underperform Votes:  362 (Vote Underperform)
Total Votes:  769
MarketBeat's community ratings are surveys of what our community members think about II-VI and other stocks. Vote "Outperform" if you believe IIVI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IIVI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel